NYSE · CIK 0002105398
CSQR Csquare, Inc.
Insider trading from SEC Form 4. Last filing Jul 20, 2026.
In brief
Csquare, Inc. (CSQR) has 7 SEC Form 4 filings on file from 7 insiders, the latest filed on Jul 20, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at Csquare, Inc., scored.
Transactions
Every row filed, 13 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 16, 2026 | Philip M Kelley director | AGrant or award Common Stock | +10,000 | $21.00 | $210k | 10,000 | Jul 20, 2026 |
| Jul 16, 2026 | Terri Pizzuto director | AGrant or award Common Stock | +3,600 | $21.00 | $76k | 3,600 | Jul 20, 2026 |
| Jul 15, 2026 | Sean Patrick Charnock Chief Operating Officer | AGrant or award Common Stock | +266,666 | $21.00 | $5.6M | 266,666 | Jul 17, 2026 |
| Jul 15, 2026 | Steven R. E. Cook Chief Financial Officer | AGrant or award Common Stock | +380,952 | $21.00 | $8.0M | 380,952 | Jul 17, 2026 |
| Jul 15, 2026 | Spencer Edward Mullee Chief Executive Officer | AGrant or award Common Stock | +3,571,427 | $21.00 | $75M | 3,571,427 | Jul 17, 2026 |
| Jul 15, 2026 | Andrea Renee White Chief Accounting Officer | AGrant or award Restricted Stock Unitsderivative | +11,904 | $0.00 | $0 | 11,904 | Jul 17, 2026 |
| Jul 15, 2026 | Smith Catherine A. Simmons Please see "Remarks" | AGrant or award Common Stock | +419,046 | $21.00 | $8.8M | 419,046 | Jul 17, 2026 |
| Jul 15, 2026 | Sean Patrick Charnock Chief Operating Officer | AGrant or award Restricted Stock Unitsderivative | +330,142 | $0.00 | $0 | 330,142 | Jul 17, 2026 |
| Jul 15, 2026 | Steven R. E. Cook Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +275,119 | $0.00 | $0 | 275,119 | Jul 17, 2026 |
| Jul 15, 2026 | Smith Catherine A. Simmons Please see "Remarks" | AGrant or award Restricted Stock Unitsderivative | +110,047 | $0.00 | $0 | 110,047 | Jul 17, 2026 |
| Jul 15, 2026 | Sean Patrick Charnock Chief Operating Officer | AGrant or award Restricted Stock Unitsderivative | +21,428 | $0.00 | $0 | 21,428 | Jul 17, 2026 |
| Jul 15, 2026 | Steven R. E. Cook Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +21,428 | $0.00 | $0 | 21,428 | Jul 17, 2026 |
| Jul 15, 2026 | Smith Catherine A. Simmons Please see "Remarks" | AGrant or award Restricted Stock Unitsderivative | +21,428 | $0.00 | $0 | 21,428 | Jul 17, 2026 |
Insiders
Everyone who has filed a Form 4 here.
- Sean Patrick CharnockChief Operating Officer
- Steven R. E. CookChief Financial Officer
- Philip M Kelleydirector
- Spencer Edward MulleeChief Executive Officer
- Terri Pizzutodirector
- Smith Catherine A. SimmonsPlease see "Remarks"
- Andrea Renee WhiteChief Accounting Officer
Questions about CSQR
Answered from the filings on this page, as of the latest one.
Are insiders buying CSQR?
No. In the last 90 days no insider at Csquare, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade CSQR on the open market?
No open-market trade has been scored at Csquare, Inc.. The latest Form 4 on file was filed on Jul 20, 2026 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at Csquare, Inc.?
7 people have filed a Form 4 at Csquare, Inc., among them Sean Patrick Charnock (Chief Operating Officer), Steven R. E. Cook (Chief Financial Officer), Philip M Kelley (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.